Ed J. Moran
Bristol, ENG BS105NB, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Journal: The New England journal of medicine
Published: June 17, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
Journal: The Journal of infection
Published: March 18, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
Journal: The Journal of infection
Published: March 18, 2026
Estimating the effective reproduction number from wastewater (Rt): A methods comparison.
Journal: Epidemics
Published: February 26, 2025
High Mycobacterium bovis Exposure but Low IGRA Positivity in UK Farm Workers.
Journal: Zoonoses and public health
Published: June 27, 2024
Wastewater surveillance provides 10-days forecasting of COVID-19 hospitalizations superior to cases and test positivity: A prediction study.
Journal: Infectious Disease Modelling
Published: September 07, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Journal: The Lancet. Infectious diseases
Published: March 15, 2023
Informing antimicrobial stewardship with explainable AI.
Journal: PLOS digital health
Published: August 17, 2022
Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review.
Journal: Clinical infection in practice
Published: July 03, 2022
Coughs and sneezes spread diseases: but do 'aerosol generating' procedures?
Journal: Thorax
Published: October 28, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Journal: Lancet (London, England)
Published: September 24, 2021
Last Updated: 09/26/2026